CLEAN ENERGY FUELS CORP (CLNE) Fundamental Analysis & Valuation

NASDAQ:CLNE • US1844991018

Current stock price

2.12 USD
0 (0%)
At close:
2.1031 USD
-0.02 (-0.8%)
After Hours:

This CLNE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. CLNE Profitability Analysis

1.1 Basic Checks

  • In the past year CLNE was profitable.
  • CLNE had a positive operating cash flow in the past year.
  • In the past 5 years CLNE always reported negative net income.
  • In the past 5 years CLNE always reported a positive cash flow from operatings.
CLNE Yearly Net Income VS EBIT VS OCF VS FCFCLNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M

1.2 Ratios

  • The Return On Assets of CLNE (-21.01%) is worse than 88.46% of its industry peers.
  • CLNE has a Return On Equity of -39.69%. This is amonst the worse of the industry: CLNE underperforms 83.65% of its industry peers.
Industry RankSector Rank
ROA -21.01%
ROE -39.69%
ROIC N/A
ROA(3y)-11.86%
ROA(5y)-10.15%
ROE(3y)-21.67%
ROE(5y)-17.13%
ROIC(3y)N/A
ROIC(5y)N/A
CLNE Yearly ROA, ROE, ROICCLNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20 -30

1.3 Margins

  • CLNE's Gross Margin of 27.05% is on the low side compared to the rest of the industry. CLNE is outperformed by 61.06% of its industry peers.
  • In the last couple of years the Gross Margin of CLNE has declined.
  • CLNE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.37%
GM growth 5Y-5.79%
CLNE Yearly Profit, Operating, Gross MarginsCLNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

4

2. CLNE Health Analysis

2.1 Basic Checks

  • CLNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, CLNE has less shares outstanding
  • CLNE has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CLNE has a worse debt to assets ratio.
CLNE Yearly Shares OutstandingCLNE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
CLNE Yearly Total Debt VS Total AssetsCLNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • CLNE has an Altman-Z score of -0.74. This is a bad value and indicates that CLNE is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -0.74, CLNE is not doing good in the industry: 71.15% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of CLNE is 8.99, which is on the high side as it means it would take CLNE, 8.99 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of CLNE (8.99) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.41 indicates that CLNE is not too dependend on debt financing.
  • CLNE has a Debt to Equity ratio of 0.41. This is comparable to the rest of the industry: CLNE outperforms 54.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 8.99
Altman-Z -0.74
ROIC/WACCN/A
WACC7.53%
CLNE Yearly LT Debt VS Equity VS FCFCLNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • CLNE has a Current Ratio of 2.32. This indicates that CLNE is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of CLNE (2.32) is better than 78.37% of its industry peers.
  • A Quick Ratio of 2.03 indicates that CLNE has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 2.03, CLNE is doing good in the industry, outperforming 76.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 2.03
CLNE Yearly Current Assets VS Current LiabilitesCLNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

6

3. CLNE Growth Analysis

3.1 Past

  • CLNE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -75.00%.
  • The earnings per share for CLNE have been decreasing by -20.63% on average. This is quite bad
  • The Revenue has been growing slightly by 2.16% in the past year.
  • Measured over the past years, CLNE shows a small growth in Revenue. The Revenue has been growing by 7.81% on average per year.
EPS 1Y (TTM)-75%
EPS 3Y-20.63%
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)2.16%
Revenue growth 3Y0.37%
Revenue growth 5Y7.81%
Sales Q2Q%2.74%

3.2 Future

  • CLNE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 143.54% yearly.
  • The Revenue is expected to grow by 26.27% on average over the next years. This is a very strong growth
EPS Next Y-530.13%
EPS Next 2Y42.83%
EPS Next 3Y269.48%
EPS Next 5Y143.54%
Revenue Next Year2.93%
Revenue Next 2Y9.74%
Revenue Next 3Y30.49%
Revenue Next 5Y26.27%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CLNE Yearly Revenue VS EstimatesCLNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
CLNE Yearly EPS VS EstimatesCLNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 -1

2

4. CLNE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 212.00, the valuation of CLNE can be described as expensive.
  • Based on the Price/Earnings ratio, CLNE is valued a bit more expensive than 68.75% of the companies in the same industry.
  • CLNE is valuated expensively when we compare the Price/Earnings ratio to 25.23, which is the current average of the S&P500 Index.
  • CLNE is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 212
Fwd PE N/A
CLNE Price Earnings VS Forward Price EarningsCLNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150 200

4.2 Price Multiples

  • 72.60% of the companies in the same industry are cheaper than CLNE, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, CLNE is valued a bit cheaper than the industry average as 62.02% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 18.14
EV/EBITDA 175.61
CLNE Per share dataCLNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CLNE's earnings are expected to grow with 269.48% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.83%
EPS Next 3Y269.48%

0

5. CLNE Dividend Analysis

5.1 Amount

  • CLNE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CLNE Fundamentals: All Metrics, Ratios and Statistics

CLEAN ENERGY FUELS CORP

NASDAQ:CLNE (3/20/2026, 8:00:00 PM)

After market: 2.1031 -0.02 (-0.8%)

2.12

0 (0%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-24
Earnings (Next)05-06
Inst Owners45.77%
Inst Owner Change-0.3%
Ins Owners1.1%
Ins Owner Change0.52%
Market Cap465.19M
Revenue(TTM)424.83M
Net Income(TTM)-222.02M
Analysts82.86
Price Target4.84 (128.3%)
Short Float %3.01%
Short Ratio4.24
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)100%
Min EPS beat(2)100%
Max EPS beat(2)100%
EPS beat(4)4
Avg EPS beat(4)101.5%
Min EPS beat(4)100%
Max EPS beat(4)106%
EPS beat(8)8
Avg EPS beat(8)122.72%
EPS beat(12)11
Avg EPS beat(12)122.29%
EPS beat(16)14
Avg EPS beat(16)89.29%
Revenue beat(2)2
Avg Revenue beat(2)2.88%
Min Revenue beat(2)1.54%
Max Revenue beat(2)4.22%
Revenue beat(4)4
Avg Revenue beat(4)2.47%
Min Revenue beat(4)0.28%
Max Revenue beat(4)4.22%
Revenue beat(8)7
Avg Revenue beat(8)1.09%
Revenue beat(12)8
Avg Revenue beat(12)1.43%
Revenue beat(16)9
Avg Revenue beat(16)-0.57%
PT rev (1m)0%
PT rev (3m)4.26%
EPS NQ rev (1m)-12.48%
EPS NQ rev (3m)-20.94%
EPS NY rev (1m)-3.87%
EPS NY rev (3m)-15.22%
Revenue NQ rev (1m)-0.34%
Revenue NQ rev (3m)-0.34%
Revenue NY rev (1m)0.45%
Revenue NY rev (3m)2.64%
Valuation
Industry RankSector Rank
PE 212
Fwd PE N/A
P/S 1.09
P/FCF 18.14
P/OCF 5.44
P/B 0.83
P/tB 0.85
EV/EBITDA 175.61
EPS(TTM)0.01
EY0.47%
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)0.12
FCFY5.51%
OCF(TTM)0.39
OCFY18.39%
SpS1.94
BVpS2.55
TBVpS2.5
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.76
Profitability
Industry RankSector Rank
ROA -21.01%
ROE -39.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.05%
FCFM 6.04%
ROA(3y)-11.86%
ROA(5y)-10.15%
ROE(3y)-21.67%
ROE(5y)-17.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.37%
GM growth 5Y-5.79%
F-Score4
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 8.99
Debt/EBITDA 74.68
Cap/Depr 60.73%
Cap/Sales 14.1%
Interest Coverage N/A
Cash Conversion 2785.96%
Profit Quality N/A
Current Ratio 2.32
Quick Ratio 2.03
Altman-Z -0.74
F-Score4
WACC7.53%
ROIC/WACCN/A
Cap/Depr(3y)168.33%
Cap/Depr(5y)133.37%
Cap/Sales(3y)20.62%
Cap/Sales(5y)17.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-75%
EPS 3Y-20.63%
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-530.13%
EPS Next 2Y42.83%
EPS Next 3Y269.48%
EPS Next 5Y143.54%
Revenue 1Y (TTM)2.16%
Revenue growth 3Y0.37%
Revenue growth 5Y7.81%
Sales Q2Q%2.74%
Revenue Next Year2.93%
Revenue Next 2Y9.74%
Revenue Next 3Y30.49%
Revenue Next 5Y26.27%
EBIT growth 1Y-238.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year146.99%
EBIT Next 3Y43.23%
EBIT Next 5Y32.3%
FCF growth 1Y266.77%
FCF growth 3Y24.69%
FCF growth 5Y-11.7%
OCF growth 1Y32.44%
OCF growth 3Y8.63%
OCF growth 5Y6.98%

CLEAN ENERGY FUELS CORP / CLNE Fundamental Analysis FAQ

What is the fundamental rating for CLNE stock?

ChartMill assigns a fundamental rating of 3 / 10 to CLNE.


What is the valuation status of CLEAN ENERGY FUELS CORP (CLNE) stock?

ChartMill assigns a valuation rating of 2 / 10 to CLEAN ENERGY FUELS CORP (CLNE). This can be considered as Overvalued.


Can you provide the profitability details for CLEAN ENERGY FUELS CORP?

CLEAN ENERGY FUELS CORP (CLNE) has a profitability rating of 1 / 10.


What is the valuation of CLEAN ENERGY FUELS CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CLEAN ENERGY FUELS CORP (CLNE) is 212 and the Price/Book (PB) ratio is 0.83.


What is the earnings growth outlook for CLEAN ENERGY FUELS CORP?

The Earnings per Share (EPS) of CLEAN ENERGY FUELS CORP (CLNE) is expected to decline by -530.13% in the next year.